(Q71835782)

English

Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay

scientific article published on 01 January 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

bioluminescence

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C M Kurbacher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

I A Cree

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

U Brenne

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

H W Bruckner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J A Kurbacher

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Mallmann

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P E Andreotti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

D Krebs

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

161-170

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of MTT and ATP-based assays for the measurement of viable cell number

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contribution of medicine to the primary treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of titanocenedichloride versus cisplatin and doxorubicin in primary and recurrent epithelial ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of titanocenedichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of mitoxantrone and doxorubicin in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving concepts in the systemic adjuvant treatment of breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comment on mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I-II study of intensive-dose adriamycin for advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human tumor clonogenic assay in human breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth characteristics of nonmalignant cells in the ATP cell viability assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct cloning of human breast cancer in soft agar culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone (novantrone): a review of experimental and early clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8944334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01807161

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8944334%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71835782&oldid=2220795615"